Treatment follow-up reveals positive results for MS patients
Treatment follow-up reveals positive results for MS patients
Results from the BENEFIT11 trial has found that early treatment with IFNB-1b leads to improvements in cognition and fatigue in the long-term, as well as sustained employment and favourable magnetic resonance imaging (MRI) outcomes, measured at the 11-year mark, according to the study Long-Term Impact Of Early MS Treatment With Interferon Beta-1b: Clinical, MRI, Employment And Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11)...... Read More - http://www.ms-uk.org/betaferon
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1042 Views
-
Last post by frodo
-
- 8 Replies
- 7197 Views
-
Last post by Algis
-
- 1 Replies
- 1154 Views
-
Last post by Scott1
-
- 1 Replies
- 1696 Views
-
Last post by frodo
-
- 0 Replies
- 1346 Views
-
Last post by frodo
-
- 0 Replies
- 1392 Views
-
Last post by NHE
-
- 0 Replies
- 2095 Views
-
Last post by frodo
-
- 5 Replies
- 11862 Views
-
Last post by gibbledygook
-
- 5 Replies
- 2244 Views
-
Last post by Jaded